Abstract
A review of the clinical manifestations of alpha(1)-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.
| Original language | English |
|---|---|
| Title of host publication | Thorax |
| Volume | 59(5) |
| Publication status | Published - 1 Jan 2004 |